Medicine for treating alcoholic liver diseases

Abstract

The invention relates to a medicine and provides a medicine for treating alcoholic liver diseases. The medicine is characterized by comprising Chinese herbal medicines in parts by weight as follows: 10-60 parts of buffalo horn powder, 5-20 parts of rhubarb, 15-60 parts of lalang grass rhizomes, 5-15 parts of golden thread, 10-30 parts of moutan bark, 10-30 parts of red paeony roots, 5-20 parts of safflower, 10-60 parts of clam shell powder, 5-20 parts of rootlets of Chinese angelica, 10-30 parts of roots of sachalin raspberry and 1-5 parts of burnt hair. The medicine has the functions of toxin elimination, inflammation resistance, liver protection, lipid lowering and fibrosis resistance, is suitable for alcoholic fatty liver, alcoholic hepatitis, alcoholic hepatic fibrosis and alcoholic cirrhosis in the compensatory stage, and has a remarkable clinical treatment effect.

Description

technical field [0001] The invention relates to a medicine, especially a medicine for treating alcoholic liver disease. Background technique [0002] Alcoholic liver disease is caused by long-term heavy drinking. Long-term drinking generally exceeds five years, equivalent to alcohol content: men ≥ 40g / d, women ≥ 20g / d, or have a history of heavy drinking within two weeks, equivalent to alcohol content ≥ 80g / d; the initial stage usually manifests as fatty liver, and then develops into Alcoholic hepatitis, alcoholic liver fibrosis and alcoholic liver cirrhosis, severe alcoholism can induce extensive liver cell necrosis and even liver failure; alcoholic liver disease is already one of the important causes of liver cirrhosis in my country, and there is a growing trend . [0003] At present, Western medicine has no definite treatment for alcoholic liver disease. Its treatment principles are alcohol abstinence, nutritional support, removal of fatty liver deposits, treatment of alc...

AI Technical Summary

Problems solved by technology

The current clinical drug treatment, such as the application of steroid hormones, can improve the short-term survival rate of patients; pentoxifylline can reduce the occurrence of hepatorenal syndrome and improve the survival rate of patients; Infection and other adverse reactions; the application of antioxidants, S-glycoside-L-methionine, and lipid-lowering drugs has uncertain efficacy and is still controversial